Last updated: 2026-09-06 09:03:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Personalis, Inc. (PSNL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $17.20, with a market capitalization of $1.79B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.73 to $18.89. This page covers its latest market performance, valuation, price trends and company information.
$1.79B | |
$16.75 | |
$53.46 | |
$0.89 | |
$16.83 | |
2.44M | |
-- | |
-- | |
$18.89 | |
$4.73 | |
-- | |
-- |
Personalis, Inc. (PSNL) last closed at $16.83 as of 2026-09-04 23:44:00, unchanged from the previous close of $16.83.
During the latest regular trading session, PSNL traded between $0.89 and $53.46, with a volume of 2.44M shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Personalis, Inc. (PSNL) moved from $17.00 to $17.20, representing a gain of 1.16% ($0.20).
The stock traded between $16.58 and $17.20 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 3.09 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 88.1%
PSNL is currently trading at $17.20, placing it 88.1% of the way from its 52-week low of $4.73 to its 52-week high of $18.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 260 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Personalis, Inc. (PSNL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.